$CKX
CKX LANDS, INC.

2023 Q4 Form 10-Q Financial Statement

#000143774923031306 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $690.4K $259.0K $330.2K
YoY Change 143.86% -21.56% 90.28%
Cost Of Revenue $27.90K $7.890K $21.36K
YoY Change -22.99% -63.06% 37.63%
Gross Profit $662.5K $251.1K $308.9K
YoY Change 168.34% -18.69% 95.45%
Gross Profit Margin 95.96% 96.95% 93.53%
Selling, General & Admin $302.8K $246.3K $411.2K
YoY Change -82.14% -40.11% 191.33%
% of Gross Profit 45.7% 98.06% 133.13%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.210K $1.065K $711.00
YoY Change -63.11% 49.79% 40.24%
% of Gross Profit 0.18% 0.42% 0.23%
Operating Expenses $303.8K $247.3K $411.9K
YoY Change -82.11% -39.95% 190.79%
Operating Profit $358.7K $3.813K -$97.36K
YoY Change -124.72% -103.92% -135.06%
Interest Expense $55.06K $43.76K $9.110K
YoY Change 178.36% 380.35% 151.66%
% of Operating Profit 15.35% 1147.65%
Other Income/Expense, Net $0.00 $70.00 $0.00
YoY Change -100.0%
Pretax Income $413.8K $47.64K -$88.25K
YoY Change -129.15% -153.98% -131.37%
Income Tax $172.1K $11.91K -$36.55K
% Of Pretax Income 41.6% 25.0%
Net Earnings $241.6K $35.73K -$51.70K
YoY Change -124.31% -169.11% -127.43%
Net Earnings / Revenue 35.0% 13.79% -15.66%
Basic Earnings Per Share $0.02 -$0.03
Diluted Earnings Per Share $0.11 $0.02 -$26.21K
COMMON SHARES
Basic Shares Outstanding 1.974M 1.974M 1.964M
Diluted Shares Outstanding 2.285M 1.973M

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.072M $8.534M $7.888M
YoY Change 11.27% 8.19% -0.03%
Cash & Equivalents $7.547M $7.026M $7.383M
Short-Term Investments $1.525M $1.508M $505.1K
Other Short-Term Assets $212.3K $145.4K $136.9K
YoY Change 639.65% 6.19% 163.39%
Inventory
Prepaid Expenses
Receivables $104.7K $66.72K $97.44K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $9.389M $8.747M $8.122M
YoY Change 13.01% 7.68% 1.49%
LONG-TERM ASSETS
Property, Plant & Equipment $9.095M $9.097M $9.083M
YoY Change 0.17% 0.15% -0.03%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $329.1K $332.9K
YoY Change 9.69%
Total Long-Term Assets $9.425M $9.430M $9.083M
YoY Change 0.48% 3.82% -0.03%
TOTAL ASSETS
Total Short-Term Assets $9.389M $8.747M $8.122M
Total Long-Term Assets $9.425M $9.430M $9.083M
Total Assets $18.81M $18.18M $17.21M
YoY Change 6.37% 5.64% 0.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $159.2K $23.24K $82.49K
YoY Change 322.96% -71.83% -26.4%
Accrued Expenses
YoY Change
Deferred Revenue $184.8K $94.83K $121.4K
YoY Change -19.5% -21.91% -39.8%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $495.3K $118.1K $203.9K
YoY Change 85.4% -42.1% -37.05%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $495.3K $118.1K $203.9K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $495.3K $118.1K $391.6K
YoY Change 85.4% -69.85% -23.46%
SHAREHOLDERS EQUITY
Retained Earnings $15.37M $15.13M $16.22M
YoY Change 0.94% -6.74% -1.78%
Common Stock $59.34K $59.34K $59.34K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $176.6K
YoY Change
Treasury Stock Shares $14.27K
Shareholders Equity $18.32M $18.06M $16.81M
YoY Change
Total Liabilities & Shareholders Equity $18.81M $18.18M $17.21M
YoY Change 6.37% 5.64% 0.69%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income $241.6K $35.73K -$51.70K
YoY Change -124.31% -169.11% -127.43%
Depreciation, Depletion And Amortization $1.210K $1.065K $711.00
YoY Change -63.11% 49.79% 40.24%
Cash From Operating Activities $624.5K $148.2K $315.4K
YoY Change 162.86% -53.0% 242500.0%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities -$17.13K -$1.508M $3.420K
YoY Change -96.37% -44195.03% -98.71%
Cash From Investing Activities -$17.14K -$1.508M $3.420K
YoY Change -96.37% -44194.74% -98.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -87.16K 0.000 -45.25K
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 624.5K 148.2K 315.4K
Cash From Investing Activities -17.14K -1.508M 3.420K
Cash From Financing Activities -87.16K 0.000 -45.25K
Net Change In Cash 520.2K -1.360M 273.6K
YoY Change -321.6% -597.1% 6.15%
FREE CASH FLOW
Cash From Operating Activities $624.5K $148.2K $315.4K
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow $624.5K $148.2K $315.4K
YoY Change 162.86% -53.0% 3979.95%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Net Income Loss
NetIncomeLoss
-98679 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
16606187 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
0 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
126423 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
37626 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
94826 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
118064 usd
CY2023Q3 us-gaap Liabilities
Liabilities
118064 usd
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1974427
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
59335 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3044871 usd
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
14274
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18176133 usd
CY2023Q3 us-gaap Revenues
Revenues
259031 usd
us-gaap Depreciation
Depreciation
3196 usd
us-gaap Depreciation
Depreciation
1901 usd
CY2023Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-0 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
149992 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
5667 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
255218 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
427593 usd
us-gaap Costs And Expenses
CostsAndExpenses
1032067 usd
us-gaap Costs And Expenses
CostsAndExpenses
1227090 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3813 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-97361 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-236894 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-404728 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
43755 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
9107 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
105248 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
15563 usd
CY2023Q3 ckx Miscellaneous Income
MiscellaneousIncome
74 usd
CY2022Q3 ckx Miscellaneous Income
MiscellaneousIncome
0 usd
ckx Miscellaneous Income
MiscellaneousIncome
74 usd
ckx Miscellaneous Income
MiscellaneousIncome
3282 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
47642 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-88254 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-131572 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-385883 usd
CY2023Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-36551 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-62229 usd
CY2023Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
11910 usd
CY2022Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-32893 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11910 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-36551 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-32893 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-62229 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
35732 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-51703 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1974427
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1972714
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1974427
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1954012
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1974427
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1954012
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
17916832 usd
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
310794
us-gaap Depletion
Depletion
737 usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0000352955
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 pure
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
0 usd
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
176592 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
15130455 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
18058069 usd
CY2022Q3 us-gaap Revenues
Revenues
330232 usd
us-gaap Revenues
Revenues
795173 usd
us-gaap Revenues
Revenues
822362 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
411189 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1147562 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1180832 usd
CY2023Q3 us-gaap Depreciation
Depreciation
1065 usd
CY2022Q3 us-gaap Depreciation
Depreciation
711 usd
us-gaap Net Income Loss
NetIncomeLoss
-98679 usd
us-gaap Net Income Loss
NetIncomeLoss
-323654 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2285223
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1972714
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
105505 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
35732 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
18058069 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
16617192 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
293497 usd
CY2022Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
45257 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-51703 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
16813729 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
17420414 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
736334 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
18058069 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
707788 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
176592 usd
us-gaap Net Income Loss
NetIncomeLoss
-323654 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
16813729 usd
us-gaap Net Income Loss
NetIncomeLoss
-98679 usd
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
149992 usd
us-gaap Net Income Loss
NetIncomeLoss
-323654 usd
us-gaap Depreciation
Depreciation
3196 usd
us-gaap Depreciation
Depreciation
1901 usd
us-gaap Depletion
Depletion
540 usd
us-gaap Depletion
Depletion
737 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-32892 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
0 usd
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
5667 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-0 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-504 usd
us-gaap Share Based Compensation
ShareBasedCompensation
736334 usd
us-gaap Share Based Compensation
ShareBasedCompensation
707788 usd
us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
56975 usd
us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
148203 usd
us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-149112 usd
us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-57310 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
252420 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
176096 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1508042 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2791 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
1004603 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12835 usd
ckx Payments Of Reforesting Timber Costs
PaymentsOfReforestingTimberCosts
20737 usd
ckx Payments Of Reforesting Timber Costs
PaymentsOfReforestingTimberCosts
16462 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
149992 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
5667 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-374184 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26421 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
176592 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-176592 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-121764 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-26917 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7148207 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7409873 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7026443 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7382956 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
16947 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Concentration of Credit Risk</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company maintains its cash balances in seven financial institutions. At times, cash balances may exceed the Federal Deposit Insurance Corporation’s insured limit of $250,000. The Company has not experienced any losses in such accounts and management believes the Company is not exposed to any significant credit risk on its cash balances.</p>
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
310794
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
310794
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
310794
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9187345 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9167148 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
90732 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
87536 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9096613 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9079612 usd
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
149992 usd
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
5667 usd
us-gaap Depreciation
Depreciation
3196 usd
us-gaap Depreciation
Depreciation
1901 usd
us-gaap Depletion
Depletion
540 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
71788
ckx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue
3374002 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
329131 usd
CY2022 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
14274
CY2022 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
46206

Files In Submission

Name View Source Status
ckx-20230930_cal.xml Edgar Link unprocessable
ckx-20230930_pre.xml Edgar Link unprocessable
0001437749-23-031306-index-headers.html Edgar Link pending
0001437749-23-031306-index.html Edgar Link pending
0001437749-23-031306.txt Edgar Link pending
0001437749-23-031306-xbrl.zip Edgar Link pending
ckx-20230930.xsd Edgar Link pending
ckx20230930_10q.htm Edgar Link pending
ex_593108.htm Edgar Link pending
ex_593110.htm Edgar Link pending
ex_593111.htm Edgar Link pending
ex_593112.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ckx-20230930_def.xml Edgar Link unprocessable
ckx-20230930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ckx20230930_10q_htm.xml Edgar Link completed